A Comprehensive Summary of the Third International StemNet Meeting 2026
Frontiers in Bioscience-Landmark · 2026-06-15 · 31 (6)
DOI: 10.31083/fbl53791 ↗At a glance
Journal article in Frontiers in Bioscience-Landmark, published online on 2026-06-15. Written by Enrico Ragni and 8 co-authors. Institution: Laboratorio di Biotecnologie Applicate all'Ortopedia, IRCCS Ospedale Galeazzi-Sant'Ambrogio, 20157 Milano, Italy. Major MEDLINE topics: Regenerative Medicine, Stem Cell Research. The full text is freely available (open access, CC BY 4.0). Funded by: European Union - Next Generation EU - NRRP M6C2 - Investment 2.1 Enhancement and strengthening of biomedical research in the NHS.
Abstract (original language)
The Third International StemNet Meeting, held on March 12–13, 2026, served as a landmark event uniting Italy’s four major stem cell research associations: FIRST, GISM, IPLASS, and SCRI. By integrating the unique expertise of these organizations, the meeting aimed to enhance the quality and clinical impact of regenerative medicine through proactive synergy and knowledge exchange. The scientific program, organized into six comprehensive sessions, highlighted recent advances in basic and translational research, specifically focusing on the evolution of advanced therapies such as Extracellular Vesicles and Advanced Therapy Medicinal Products (ATMPs). Beyond scientific findings, the proceedings also addressed biomedical communication and research translation, ensuring that scientific discoveries translate effectively into social and economic benefits. A significant highlight was the “Next Generation Session”, organized by early-career scientists to foster the development of the field’s future leaders. With a faculty of renowned national and international experts, the meeting facilitated rigorous debate and established a collaborative roadmap for addressing the current challenges in stem cell science and its therapeutic applications.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Laboratorio di Biotecnologie Applicate all'Ortopedia, IRCCS Ospedale Galeazzi-Sant'Ambrogio, 20157 Milano, Italy.
- Unit of Cell and Gene Therapies, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy.
- Department of Experimental Medicine, Campania University "Luigi Vanvitelli", 80138 Napoli, Italy.
- Dipartimento di Scienze Biomolecolari (DISB), Università degli Studi di Urbino "Carlo Bo", 61029 Urbino, Italy.
- Centro di Ricerca E. Menni, Fondazione Poliambulanza Istituto Ospedaliero, 25124 Brescia, Italy.
- Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Funding
- European Union - Next Generation EU - NRRP M6C2 - Investment 2.1 Enhancement and strengthening of biomedical research in the NHS
Cite
APA
Ragni, E., Elia, N., Galderisi, U., Iachini, M. C., Lazzari, L., Marrazzo, P., Silini, A. R., Taiana, M. M., & Lucarelli, E. (2026). A Comprehensive Summary of the Third International StemNet Meeting 2026. Frontiers in Bioscience-Landmark, 31(6). https://doi.org/10.31083/fbl53791
Vancouver
Ragni E, Elia N, Galderisi U, Iachini MC, Lazzari L, Marrazzo P, et al. A Comprehensive Summary of the Third International StemNet Meeting 2026. Frontiers in Bioscience-Landmark. 2026;31(6). doi:10.31083/fbl53791
BibTeX
@article{Ragni2026,
author = {Ragni, Enrico and Elia, Noemi and Galderisi, Umberto and Iachini, Maria Chiara and Lazzari, Lorenza and Marrazzo, Pasquale and Silini, Antonietta Rosa and Taiana, Michela Maria and Lucarelli, Enrico},
title = {A Comprehensive Summary of the Third International StemNet Meeting 2026},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
volume = {31},
number = {6},
doi = {10.31083/fbl53791}
}
EUVIMED